PATENT CLAIM ANALYSIS

Application Number: 16079162
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "233800"]

Abstract:
The invention relates to acid addition salts of piperazine derivatives, as well as solid forms, such as polymorphic forms, thereof, which are useful as pharmaceutical ingredients and, in particular, as glycosidase inhibitors.

Claim (Index 21):
N-(5-{4-[(1S)-1-(2H-1,3-benzodioxol-5-yl)ethyl]piperazin-1-yl}-1,3,4-thiadiazol-2-yl)acetamide, mono-hydrochloride in a solid form having the characteristic X-ray powder diffraction pattern as shown on  FIG. 11 .

Metadata:
- Claim Count in Document: 32.0
- Percentile: 96.0
- Lexical Diversity: 1.34483
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15830675', '16078715', '15507375', '14502213', '15539147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7557641448324998
- 35 USC 102 Novelty (BERT): 0.5288503421718742
- Combined Prediction Score: 0.7330727645664372
- Mean Citation Score: 296.0521720000001
- Max Citation Score: 318.7650799999999
- Similarity Product: 226.213095659151

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test